Original Research

Clinical, Original Research

A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making

Madison M. Wempe, BS; Mark D. Stewart, PhD; Daniel Glass, PhD; Laura Lasiter, PhD; Diana Merino Vega, PhD; Nisha Ramamurthy; Jeff Allen, PhD; Ellen V. Sigal, PhD

Stakeholder Perspective

Navigating the Complex World of Diagnostic Tests and Their Role in Clinical Decision-Making

James T. Kenney, RPh, MBA

Business, Original Research

Budget Impact Analysis of a Home-Based Nutrition Program for Adults at Risk for Malnutrition

Suela Sulo, PhD, MSc; David Lanctin, MPH; Josh Feldstein, BA; Bjoern Schwander, MA, RN; Jamie Partridge, PhD, MBA; Wendy Landow, MPH; York F. Zöllner, MSc

Business, Original Research

Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018

Zizi Elsisi, BPharm; Ana L. Hincapie, PhD; Jeff Jianfei Guo, BPharm, PhD

Stakeholder Perspective

Utilization Challenges of Drugs for Multiple Sclerosis in a Medicaid Population

James T. Kenney, RPh, MBA

Clinical, Original Research

Mental Health Conditions and Hospitalizations for Ambulatory Care Sensitive Conditions Among Veterans with Diabetes

Drew A. Helmer, MD, MS; Nilanjana Dwibedi, BPharm, MBA, PhD; Mazhgan Rowneki, MPH; Chin-Lin Tseng, DrPH; Dennis Fried, PhD; Danielle Rose, PhD; Nisha Jani, MPH, PhD; Usha Sambamoorthi, PhD

Stakeholder Perspective

Mental Health Conditions Constitute Significant Comorbidity: The Impact on Potentially Avoidable Hospital Admissions

Gary M. Owens, MD

Business, Original Research

Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization

Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH

Stakeholder Perspective

Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?

Atheer A. Kaddis, PharmD

Clinical, Original Research

Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan

Qingqing Xu, MS; Sarah S. Laxa, PharmD; Omar Serna, PharmD, BCACP; Sujit S. Sansgiry, MS, PhD

Stakeholder Perspective

Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence

F. Randy Vogenberg, PhD, FASHP

Clinical, Original Research

Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis

Rajeshwari Punekar, MPH, PhD; Jeannie Choi, PharmD; Susan Boklage, MS, MPH; Melitza Iglesias-Rodriguez, MD; Kamala Nola, PharmD, MS

Business, Original Research

The Economic Implications of Hyperkalemia in a Medicaid Managed Care Population

Nihar R. Desai, MD, MPH; Pamala Reed, DrPH, MPH; Paula J. Alvarez, RPh, MBA, MPH; Jeanene Fogli, PhD, RD; Steven D. Woods, PharmD; Mary Kay Owens, RPh, CPh

Stakeholder Perspective

The Impact of Quality Care on a Medicaid Population with Hyperkalemia

Byron C. Scott, MD, MBA

Business, Original Research

Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia

David Campbell, PharmD, MS; Marlo Blazer, PharmD, BCOP; Lisa Bloudek, PharmD, MS; John Brokars, MS; Dinara Makenbaeva, MD, MBA

Stakeholder Perspective

The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs

James T. Kenney, RPh, MBA

Business, Original Research

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States

Michael C. Runken, PharmD; Joshua M. Noone, PhD; Christopher M. Blanchette, PhD, MBA; Emily Zacherle, MS; Reuben Howden, PhD